HAL vs INMB · P/E 9.3, $19.05B cap vs rev $14.0K
Halliburton Company (HAL) versus INmune Bio Inc (INMB) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported INMB revenue for 2024-12-31 was $14.0K. Net income was -$42.1M. Revenue was down 91.0% from 2023-12-31 to 2024-12-31. INMB currently screens at market cap $33.5M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. INMB currently screens at market cap $33.5M.
Not investment advice. Open the HAL and INMB stock pages for the full models.
Not investment advice.